Close Menu

NEW YORK (360Dx) – Quidel announced late Tuesday that it's point-of-care Sofia 2 Lyme+ fluorescent immunoassay has received CE mark. The test has been tailored to the European market.

Quidel received clearance and CLIA waiver from the US Food and Drug Administration for its Sofia 2 Lyme test earlier this year.   

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.